med fusion clin-labs supports “Choosing Wisely®”, an initiative recently announced by the American Society of Clinical Pathology (ASCP), urging physicians and patients to engage in important conversations about some medical tests and procedures that may provide little benefit and in some cases actually harm.

“Choosing Wisely” means questioning is it the: “right test, right patient, right time, at the right cost,” and outlines five tests or batteries of tests which may have little to no benefit in certain clinical circumstances. Click here for more information.

From its start, med fusion has been in synch with the principles set forth by the “Choosing Wisely” campaign as demonstrated by our company policy on the five tests listed by the ASCP, which follow:

1. Vitamin D-25 hydroxy screening in the general population without specific indications. med fusion collects specific clinical information with each ordered test, the ICD-9 code, which provides the patient’s specific clinical condition which is associated with the need for a particular test. med fusion retrospectively monitors these ICD-9 codes by ordered test to identify ordering patterns which may signal general population screening in otherwise asymptomatic patients.
2. Do not perform low-risk human papillomavirus (HPV) testing. med fusion was an early adopter of the Roche HPV molecular assay, which will detect high-risk viral types, and will specifically identify types 16 and/or 18, which have been shown to significantly increase the risk of cervical cancer.
3. Do not perform pre-operative laboratory screening in healthy patients undergoing low-risk surgical procedures. med fusion does not offer testing panels which are identified as “Pre-operative screens”, but focused instead on specific tests which are needed to assess specific clinical conditions, associated with the ICD-9 coding system outlined under item 1 above.
4. Only order Methylated Septin 9 testing on patients for whom conventional diagnostics are not possible. med fusion does not offer this test, instead focusing on more traditional measures of increased fecal occult blood.
5. Do not use Bleeding Time tests to guide patient care. med fusion does not offer this test.